In Q1 2026, synthetic biology's design layer became AI-native. Three events in a single quarter · a $400M IPO for generative biology, the largest AI biologics financing on record, and 36,000 autonomous lab experiments published in a peer-reviewed preprint · define where the sector is. None of this required insider access to read.